Marketing & Strategy
91% of clinicians use reprints to improve patient care
For doctors, getting patient care right can be a case of life or death. They need to stay up to date with the latest research in their field, but that takes time – something that’s in short supply. It would seem logical, then, that doctors would welcome relevant and important medical studies in their inboxes, which they could use when diagnosing and treating patients.
With this in mind, pharmaceutical companies often sponsor and distribute reprints – republished versions of medical studies that doctors can use in their work, which are emailed to them for free.
Elsevier recently carried out an APAC based survey of physicians (download below) to find out whether doctors find these reprints useful, and to what extent reprints impact their work with patients. Carried out in December 2018 and January 2019, the survey asked physicians to share their experience using reprints.
The aim of the research was to understand how primary care physicians and specialists access and use scientific articles in reprint format, and why they choose certain content.
The responses provided insights across care areas: 343 physicians from APAC responded; about 80 percent were medical specialists and 20 percent were general practitioners.
Download the medical reprints infographic
Digital & Innovation
Medical drone to reduce health equity gaps in rural and remote Australia
A specialised medical drone which increases accessibility to essential health services such as pathology, medicines, and telehealth services in rural […]
MoreNews & Trends - Pharmaceuticals
We’ve spent more on healthcare, but it’s been worth it
Healthcare expenditure is surging, with Australia now allocating approximately one-tenth of its budget to this sector. This financial uptick prompts […]
MoreNews & Trends - Pharmaceuticals
New partnership to raise the bar in precision oncology in Queensland
Pharma News: The Australian Translational Genomics Centre (ATGC) is teaming up with non-profit research organisation Omico and the PrOSPeCT program […]
MoreNews & Trends - Biotechnology
AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm
Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]
More